Moneycontrol PRO
you are here: HomeNewsCovishield
covishield
Jump to
  • Covishield immune responses against Covid variants higher than Covaxin: Study January 07, 2023 01:42 PM IST

    Covishield immune responses against Covid variants higher than Covaxin: Study

    Vaccination following exposure to the Delta or Omicron variants of SARS-CoV-2 is likely to affect the quality, quantity and duration of immune responses.

  • Serum Institute to start free COVID vaccine supply to government, other manufacturers await order January 03, 2023 01:49 PM IST

    Serum Institute to start free COVID vaccine supply to government, other manufacturers await order

    The government has sent a consignment list for supplying 80 lakh doses of Covishield to different consignees to Serum Institute of India, which will start the supply soon, an official said.

  • Serum Institute to provide 2 crore Covishield doses to central govt free of cost December 28, 2022 05:44 PM IST

    Serum Institute to provide 2 crore Covishield doses to central govt free of cost

    According to an official source, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute, has written to the Health Ministry offering the doses worth Rs 410 crore free of cost.

  • Bill Gates, Serum Institute get Bombay HC notice after man claims Covishield side-effects killed daughter September 03, 2022 01:03 PM IST

    Bill Gates, Serum Institute get Bombay HC notice after man claims Covishield side-effects killed daughter

    Petitioner Dilip Lunwat, the petitioner, said his daughter, a medical student, had severe headaches and vomiting after taking the vaccine in 2021. She was taken to a hospital where doctors found bleeding in her brain.

  • HC seeks response from SII, others on plea demanding Rs 1,000 crore compensation for woman's death September 02, 2022 04:39 PM IST

    HC seeks response from SII, others on plea demanding Rs 1,000 crore compensation for woman's death

    Petitioner Dilip Lunwat has also made Microsoft founder Bill Gates whose foundation had partnered with the SII, the Union government, Maharashtra government and Drug Controller of India respondents to the plea.

  • Government nod to Corbevax as precaution dose for adults vaccinated with Covaxin, Covishield August 10, 2022 07:34 PM IST

    Government nod to Corbevax as precaution dose for adults vaccinated with Covaxin, Covishield

    This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

  • Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield August 10, 2022 11:37 AM IST

    Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

    This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

  • COVID-19 shots administered in India about to overtake count in all of Europe, North America June 20, 2022 06:10 PM IST

    COVID-19 shots administered in India about to overtake count in all of Europe, North America

    This is a remarkable feat, considering that all the vaccine doses administered in the country are made locally

  • Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin  June 06, 2022 01:30 PM IST

    Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin 

    The pharma regulator has approved the first mix-and-match of COVID-19 vaccines in India, but the final say-so lies with the government 

  • World's biggest vaccine maker Serum halts production with 200 million doses spare April 23, 2022 09:05 AM IST

    World's biggest vaccine maker Serum halts production with 200 million doses spare

    The Serum Institute has produced more than one billion doses of Covishield -- its version of the AstraZeneca jab -- and is a major supplier to the Covax global inoculation programme for poorer countries.

  • India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: Study April 16, 2022 01:34 PM IST

    India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: Study

    The heat-tolerant COVID-19 vaccine candidate can be stored at 37 degrees Celsius for four weeks and at 100 degrees Celsius for up to 90 minutes.

  • Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt April 12, 2022 07:32 PM IST

    Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt

    New Delhi, Apr 12 Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose..

  • SII to give free Covishield vials to private vaccination centres to compensate for price difference April 10, 2022 02:43 PM IST

    SII to give free Covishield vials to private vaccination centres to compensate for price difference

    The inventories at the private CVCs would be verified by SII representatives and the claim would then be processed on the basis of their approval.

  • Moneycontrol Daily: Your Essential 7 April 10, 2022 07:30 AM IST

    Moneycontrol Daily: Your Essential 7

    A daily round-up of the most interesting articles to help jump-start the day.

  • Covaxin, Covishield prices slashed to Rs 225 per shot, a day before precaution drive starts April 09, 2022 05:20 PM IST

    Covaxin, Covishield prices slashed to Rs 225 per shot, a day before precaution drive starts

    While prices for the Covishield doses were brought down from Rs 600 a shot, Covaxin was slashed from Rs 1,200.

  • For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla April 08, 2022 05:09 PM IST

    For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

    "In 10-14 days, Covovax can be available on CoWin at about Rs 900 plus tax," the SII chief executive said.

  • Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away March 23, 2022 03:17 PM IST

    Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away

    Private healthcare providers struggling to use up their stocks of Covishield and Covaxin shots are showing no enthusiasm for the Corbevax vaccination of children.

  • Explainer: Intranasal vaccine against COVID-19 and why it is awaited so eagerly March 08, 2022 03:54 PM IST

    Explainer: Intranasal vaccine against COVID-19 and why it is awaited so eagerly

    As the efficacy trials of the intranasal COVID-19 vaccine from Bharat Biotech begin this week, there are hopes that if successful, such a vaccine may finally bring the pandemic to an end

  • Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic February 18, 2022 04:20 PM IST

    Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic

    Unvaccinated tennis player Novak Djokovic has said that though he is not against COVID-19 vaccines, he will skip tournaments if compelled to take the jab.

  • Piles of unused COVID-19 jabs near expiry, private hospitals turn to government for bailout February 08, 2022 01:29 PM IST

    Piles of unused COVID-19 jabs near expiry, private hospitals turn to government for bailout

    As most vaccine beneficiaries prefer to line up at government hospitals, private hospitals now want the government to buy the doses. Of the nearly 175 crore vaccine doses administered, less than 5 percent have been in private hospitals

  • Centre spent Rs 28,436 crore on vaccination this fiscal, leaving 27% of the allocated fund unspent February 03, 2022 10:01 AM IST

    Centre spent Rs 28,436 crore on vaccination this fiscal, leaving 27% of the allocated fund unspent

    A sum of Rs 35,000 crore was originally proposed to be spent on COVID vaccination as part of 2021-22 budget which was later revised to Rs 39,000 crore. Response to an RTI query has revealed that the government has spent majority of the amount

  • Economic Survey 2022 | Only 4-5% of Covid-19 vaccine shots administered in private hospitals January 31, 2022 05:55 PM IST

    Economic Survey 2022 | Only 4-5% of Covid-19 vaccine shots administered in private hospitals

    Private hospitals were slated to be an important partner in the COVID19 vaccination drive launched in January, 2021 but barring a few initial months, their role in the massive campaign has been negligible as high prices of vaccines at private centres has kept people away.

  • Moneycontrol Daily: Your Essential 7 January 28, 2022 07:29 AM IST

    Moneycontrol Daily: Your Essential 7

    A daily round-up of the most interesting articles to help jump-start the day.

  • COVAXIN and Covishield granted regular market approval for use in adult population: Mansukh Mandaviya January 27, 2022 04:11 PM IST

    COVAXIN and Covishield granted regular market approval for use in adult population: Mansukh Mandaviya

    The Drugs Controller General of India’s (DCGI) approval came after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on January 19 recommended granting regular market approval to the Serum Institute of India’s (SII’s) Covishield and Bharat Biotech’s Covaxin for use in adult population subject to certain conditions.

  • Each dose of Covishield, Covaxin likely to be capped at Rs 275 after getting regular market approval January 26, 2022 03:58 PM IST

    Each dose of Covishield, Covaxin likely to be capped at Rs 275 after getting regular market approval

    According to official sources, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.